Company / Cash & Equivalents
NutriBand Inc. Cash & Equivalents History
FY2019-FY2026 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash & Equivalents
$4.6M
FY2026
5-year range
$492.9K / $4.9M
FY2022-FY2026
Trend
+6.1%
vs FY2025
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cash & Equivalents has fluctuated over the past 8 years, ranging from $151,993 in FY2021 to $5M in FY2022.
Based on SEC 10-K filings.
$5M in FY2026 with a 5-year CAGR of +97.6%.
Improved from $492,942 to $5M over the past 2 years.
Cash & Equivalents over time
Growth rates
- 3-Year CAGR
- +32.1%
- 5-Year CAGR
- +97.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +97.6%, indicating consistent growth.
- In FY2026, cash & equivalents increased 6.1% year-over-year.
- Peak cash & equivalents was recorded in FY2022.
- Lowest cash & equivalents in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score -1.14 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash & EquivalentsValue | YoY GrowthYoY |
|---|---|---|
| FY2026 | $4.6M | +6.1% |
| FY2025 | $4.3M | +774.7% |
| FY2024 | $492.9K | -75.2% |
| FY2023 | $2.0M | -59.4% |
| FY2022 | $4.9M | +3118.5% |
| FY2021 | $152.0K | -68.0% |
| FY2020 | $474.7K | +0.0% |
| FY2019 | $474.7K | - |
As of FY2026 · SEC 10-K · Updated Jun 28, 2026